Investing Profile

Carole Nuechterlein

VC
Photo of Carole Nuechterlein, Managing Partner at Roche Venture Fund

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
University of Michigan Network
87 CONNECTIONS
cb
Roche Venture Fund Managing Partner
10
CompanyStageDateRound SizeTotal Raised
Splice Bio
Series BJun 2025$140M
$190M
Co-investors: Ed Mathers (New Enterprise Associates (NEA)), Joël Jean-Mairet (Ysios Capital), Beat Steffen (Novartis Venture Fund), Daniela Begolo (EQT Life Sciences), Laia Crespo (Sanofi Ventures), Sylvain Sachot (Asabys Partners)
Enthera
Series AJan 2021$8M
$46M
Co-investors: Graziano Seghezzi (Soffinova Partners), Margarita Chavez (AbbVie Ventures)
Arch Oncology
Series AAug 2016$86M
$86M
Co-investors: Peter Moldt (Novo Ventures), John McKearn (RiverVest), Jill carroll (SR One)
AveXis
Series DSep 2015$65M
Series CJan 2015$10M
$75M
Co-investors: Jonathan Leff (Deerfield Management)
Lysosomal Therapeutics
Series AFeb 2015$20M
SeedMay 2014$5M
$25M
Co-investors: Clay Thorp (Hatteras Venture Partners), Bruce Booth (Atlas Venture), Bernard Davitian (Omega Funds), Reza Halse (RA Capital)
Alios BioPharma
Series BApr 2014$41M
Series AJun 2009$24M
Series AFeb 2009$8M
$74M
Co-investors: Jack Nielsen (Vivo Capital), Heath Lukatch (Red Tree Venture Capital), Jens Eckstein (Apollo Health Ventures)
Head, Roche Venture Fund F.Hoffmann-La Roche2001 - Present
General Counsel SangStat1998 - 2001
University of Michigan JD